FDA Approved: PERPHENAZINE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for PERPHENAZINE from Sandoz Inc. under ANDA 089685.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• PERPHENAZINE (Perphenazine)

Snippet

SUPPL AP for PERPHENAZINE (PERPHENAZINE)